7 Augoff K, McCue B, Plow E F, et al. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer, 2012, 11:5
[2]
10 Hossain A, Kuo M T, Saunders G F. mIR-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol, 2006, 26:8191-8201
[3]
15 Nair N, Kumar S, Gongora E, et al. Circulating miRNA as novel markers for diastolic dysfunction. Mol Cell Biochem, 2012, 1-8
[4]
16 Chang K H, Mestdagh P, Vandesompele J, et al. MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer, 2010, 10:173
[5]
17 Hurteau G J, Carlson J A, Spivack S D, et al. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res, 2007, 67:7972-7976
[6]
18 Gregory P A, Bert A G, Paterson E L, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 2008, 10:593-601
20 le Sage C, Nagel R, Egan D A, et al. Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. Embo J, 2007, 26:3699-3708
[9]
1 Imanishi T, Itoh T, Suzuki Y, et al. Integrative annotation of 21037 human genes validated by full-length cDNA clones. PLoS Biol, 2004,2:e162
[10]
2 Kapranov P, Cheng J, Dike S, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science, 2007,316:1484-1488
[11]
3 Xiao Y F, Yong X, Fan Y H, et al. microRNA detection in feces, sputum, pleural effusion and urine:Novel tools for cancer screening (Review). Oncol Rep, 2013, 30:535-544
[12]
4 Braconi C, Kogure T, Valeri N, et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene, 2011, 30:4750-4756
[13]
5 Zhang L, Yang F, Yuan J, et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis, 2013, 34:577-586
[14]
6 Yang Y, Li H, Hou S, et al. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. PLoS One, 2013, 8:e65309
[15]
8 Neves R, Scheel C, Weinhold S, et al. Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells. BMC Res Notes, 2010, 3:219
[16]
9 Chen L, Li Y, Fu Y, et al. Role of deregulated microRNAs in breast cancer progression using FFPE tissue. PLoS One, 2013, 8:e54213
[17]
11 Lombaerts M, Van Wezel T, Philippo K, et al. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Brist J Cancer, 2006, 94:661-671
[18]
12 Sempere L F, Christensen M, Silahtaroglu A, et al. Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res, 2007, 67:11612-11620
[19]
13 Valastyan S, Benaich N, Chang A, et al. Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. Gene Dev, 2009, 23:2592-2597
[20]
14 Gandhi R, Healy B, Gholipour T, et al. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol, 2013,73:729-740
[21]
21 Chen Y, Gorski D H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood, 2008, 111:1217-1226
[22]
22 Lehmann U, Hasemeier B, R？mermann D, et al. Epigenetic inactivation of microRNA genes in mammary carcinoma. Verhandlungen Deutschen Gesellschaft Pathologie (in German), 2006, 91:214-220
[23]
23 Cuk K, Zucknick M, Heil J, et al. Circulating microRNAs in plasma as early detection markers for breast cancer. Int J Cancer, 2012, 132:1602-1612
[24]
24 Garding A, Bhattacharya N, Claus R, et al. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the in cis downregulation of a gene cluster that targets NF-κB. PLoS Genet, 2013, 9:e1003373
